Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America-Reference-Cited by-同舟云学术

Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America

Published:2019-06-21 Issue:1 Volume:19 Page:
ISSN:1471-5945
Container-title:BMC Dermatology
language:en
Short-container-title:BMC Dermatol

Author:

Papp Kim A.,Gooderham Melinda,Beecker Jennifer,Lynde Charles W.,Delorme Isabelle,Dei-Cas Ignacio,Albrecht Lorne,Rampakakis Emmanouil,Sampalis John S.,Vieira Antonio,Hussein Shamiza,Chambenoit Olivier,Rihakova Lenka

Funder

Novartis Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

http://link.springer.com/content/pdf/10.1186/s12895-019-0087-3.pdf

Reference14 articles.

1. Wasel N, Poulin Y, Andrew R, Chan D, Fraquelli E, Papp K. A Canadian self-administered online survey to evaluate the impact of moderate-to-severe psoriasis among patients. J Cutan Med Surg. 2009;13(6):294–302.

2. Kimball AB, Yu AP, Signorovitch J, Xie J, Tsaneva M, Gupta SR, et al. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. J Am Acad Dermatol. 2012;66(2):e67–76.

3. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–71.